August 26, 2011
Only 25% percent of Americans are fluent in a foreign language. Compare that to 38% of UK citizens who can speak at least one other language than English. Foreign language skills are in critically short supply in the U.S., a major liability for America’s economic future and competitiveness. According to Defense Secretary Leon Panetta, it is also a major liability for U.S. military operations, as reported in Time magazine.
A decade into wars in Afghanistan and Iraq, Read more about: Pentagon’s Foreign-Language Problems »
August 19, 2011
A Chinese trademark attorney, Wayne Liu, wrote an excellent article for Managing IP magazine that’s worth sharing. The article describes how cultural differences make it difficult for foreign companies to enter the Chinese market, and that a culturally sensitive Chinese translation of foreign trademarks is a must. He cites two examples of multinational companies who have done this successfully: Microsoft (商标) and Coca-Cola (可口可乐).
The Chinese market is known for its insularity. Read more about: Translating For the Chinese Market – It’s All About The Characters »
August 12, 2011
Disputes involving document translation are not unusual during patent litigation. What is unusual is for the presiding judge to single out these translation disputes in his decision. But in Gemstar- Tvguide International Inc & Others v Virgin Media Ltd & Another  EWCA Civ 302, Lord Justice Robin Jacob did exactly that.
The case hinged on whether several Gemstar patents lacked novelty because a Toshiba patent published a month earlier disclosed the same idea clearly and unmistakeably. Read more about: Document Translation Dispute Irks Judge »
July 18, 2011
The need for pharmaceutical translation to tap into global drug markets isn’t news. But sales and growth forecasts for 2011 indicate that translations for China and other emerging markets will become more important than ever. IMS health (a pharmaceutical industry data company) predicts that the global drug market will grow 5 to 7% in 2011, to $880 billion. This is largely the result of impressive growth in prescription drug sales in 17 countries led by China, Read more about: Pharmaceutical Translation & Global Drug Market »
June 23, 2011
The BIO International Convention takes place next week in Washington, DC and Morningside will be attending (our 4th year in a row). We thought it would be timely to provide an overview on how medical translations are used by biotech companies. The need for translations can come up throughout a product’s life cycle–from R&D, to clinical trial, regulatory submission, manufacturing, and finally sales and marketing. Let’s take a closer look at the role translation services play at each stage. Read more about: BIO Preview: Translations & The Biotechnology Industry »